Central Nervous System

OVERVIEW

The Central Nervous System (CNS) session explores the latest breakthroughs in understanding and treating CNS disorders. From neurodegenerative diseases to spinal cord injuries. The Central Nervous System (CNS) is the control hub of the human body, responsible for managing a vast array of functions that are essential for life. This session is designed to provide a deep dive into the intricate workings of the CNS and its role in health and disease, inviting participants to explore both fundamental neuroscience and cutting-edge innovations. We will explore diverse topics ranging from neurodegenerative diseases to spinal cord injuries, while examining emerging technologies that aim to restore, protect, or enhance CNS function.

This session will begin by examining the development and plasticity of the CNS, looking at how the brain and spinal cord are shaped throughout life. This will include discussions on neurodevelopmental processes and the CNS's remarkable ability to adapt and reorganize in response to injury or experience. By understanding this plasticity, we can better appreciate how neurological rehabilitation can be optimized.

Neurodegenerative diseases such as Alzheimer’s and Parkinson’s will also be major focal points, as they are increasingly prevalent challenges in neuroscience and medicine. Attendees will gain insights into the latest research on the underlying mechanisms of these conditions, as well as new approaches to treatment and care. The Central Nervous System (CNS) session will explore the complexities of CNS trauma and stroke, examining both the short- and long-term impacts on individuals' lives and exploring innovative interventions aimed at promoting recovery.

One of the highlights of this session is our exploration of cutting-edge technology and its applications in CNS research. Attendees will be introduced to advancements in CNS imaging, neuroinflammation studies, and gene therapy. This session will also investigate how artificial intelligence is being applied to CNS research, providing new avenues for understanding brain function and predicting disease progression.

Key Topics:

Neurodevelopment and Plasticity of the CNS
Neurodegenerative Diseases (e.g., Alzheimer’s, Parkinson’s)
Spinal Cord Injury: Treatment and Regeneration
Neurological Effects of CNS Trauma and Stroke
Advances in CNS Imaging and Diagnostics
Neuroinflammation and CNS Immune Response
Gene Therapy and CNS-targeted Drug Delivery
CNS Tumors: New Frontiers in Research and Treatment
Artificial Intelligence in CNS Research

TOPICS

Key Discussion Areas

Core scientific themes explored across all sessions in this track.

🔬

Interventional Cardiology Advances

Latest techniques in percutaneous coronary intervention, transcatheter structural interventions, and complex bifurcation stenting with outcome data from 2025–2026 trials.

💊

Heart Failure: New Drug Classes

Comprehensive review of SGLT2 inhibitors across HFrEF/HFpEF, mavacamten in HCM, and emerging agents in the pipeline with mechanisms and clinical trial evidence.

🤖

AI in Cardiac Imaging

Clinical validation data for AI tools in echocardiography, cardiac MRI, and CT angiography — including automated ejection fraction, plaque characterisation, and anomaly detection.

🧬

Cardiac Genetics & Cardiomyopathy

CRISPR applications in hereditary cardiomyopathy, genotype-guided risk stratification, and family screening protocols in hypertrophic and dilated cardiomyopathies.

⚡

Arrhythmia & Electrophysiology

Catheter ablation advances in persistent AF, ventricular tachycardia, and SCA prevention strategies including novel antiarrhythmic drug data and wearable monitoring.

🛡️

Preventive Cardiology

Polygenic risk scores in cardiovascular prevention, novel lipid-lowering strategies beyond statins, and population health approaches to primary cardiovascular prevention.

AUDIENCE

Who Should Attend?

This track is designed for clinicians, researchers, and allied health professionals with an interest in central nervous system.

Cardiologists and cardiology trainees
Interventional cardiologists
Cardiac electrophysiologists
Heart failure specialists
Cardiothoracic surgeons
Clinical cardiac physiologists
Internal medicine physicians with cardiovascular interest
Cardiovascular nurses and allied health professionals
Cardiovascular researchers and clinical trialists

Attend Central Nervous System

Join delegates from 120+ countries for three days of world-class clinical science at the Healthcore Bridge International Medical Conference 2026.

FAQs

Frequently Asked Questions

What is the scope of the Oncology & Haematology track?

The Oncology & Haematology track covers precision oncology, immunotherapy, ADC therapies, haematological malignancies, liquid biopsy and early detection, AI in oncology, and palliative care — across 22 sessions over three conference days. It is the largest scientific track at the 2026 conference.

Will there be separate sessions for haematology and solid tumours?

Yes. The track is structured with dedicated morning sessions for haematological malignancies and afternoon sessions focusing on solid tumour oncology. The final panel each day brings all specialties together for cross-disciplinary discussion.

Are there oncology workshops available?

Yes. Two hands-on workshops complement the oncology track: a molecular tumour board simulation workshop and an AI pathology interpretation masterclass. Both require separate registration due to a 30-delegate capacity limit.

Is this track accredited for oncology-specific CME?

All oncology sessions are accredited for CME under EACCME, AMA PRA Category 1, and the Royal College of Radiologists (for radiation oncologists). Specialty-specific CME credit allocation is detailed in the conference programme and the CME pre-event delegate guide.